STBT5:Volunteer Assignments and Opportunities: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
← Older edit
VisualWikitext
No edit summary
Kathleen.Schieffer (talk | contribs)
autoreview, editor
141 edits
No edit summary
 
(50 intermediate revisions by 4 users not shown)
Line 160: Line 160:
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
|Disease
|Disease
|Kauser Begum Ravishankar (trainee), with Katie
|2/25/2026
|5/25/2026
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
|
|
|
|
Line 182: Line 182:
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
|Disease
|Disease
|Karla Sofía Peláez Valdés (trainee);
Katie Schieffer (mentor)
|3/1/2026
|
|
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
|
|
|
Line 225: Line 226:
|-
|-
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|Minimal genetic content added
|-
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
|Disease
|Disease
|
|
Line 235: Line 247:
|
|
|-
|-
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/16/2025
|Katie Schieffer
|10/16/2025
|No genetic association
|-
|[[STBT5:Elastofibroma|Elastofibroma]]
|Disease
|Disease
|
|
Line 246: Line 269:
|
|
|-
|-
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
|Disease
|Disease
|
|
Line 257: Line 289:
|
|
|-
|-
|[[STBT5:Elastofibroma|Elastofibroma]]
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|9/22/2025
|Katie Schieffer
|9/22/2025
|No genetic association
|-
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|Disease
|Disease
|
|
Line 268: Line 311:
|
|
|-
|-
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/16/2025
|Katie Schieffer
|10/16/2025
|No genetic association
|-
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|Disease
|Disease
|
|
Line 279: Line 333:
|
|
|-
|-
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|Disease
|Disease
|
|
Line 290: Line 344:
|
|
|-
|-
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
|Disease
|Disease
|
|
Line 301: Line 355:
|
|
|-
|-
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|Disease
|Disease
|
|
Line 312: Line 366:
|
|
|-
|-
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
|Disease
|Disease
|
|
Line 323: Line 377:
|
|
|-
|-
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
|Disease
|
|
|
|
|
|
|
|
|
|
Line 334: Line 408:
|
|
|-
|-
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
|Disease
|Disease
|
|
Line 345: Line 419:
|
|
|-
|-
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|No genetic association
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|Disease
|Disease
|
|
Line 356: Line 441:
|
|
|-
|-
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
|Disease
|Disease
|
|
Line 367: Line 452:
|
|
|-
|-
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|Minimal genetic content added
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|Disease
|Disease
|
|
Line 378: Line 474:
|
|
|-
|-
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
|Disease
|Disease
|
|
Line 389: Line 485:
|
|
|-
|-
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
|Disease
|Disease
|
|
Line 400: Line 496:
|
|
|-
|-
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|Disease
|Disease
|He Fang
|2/19/2026
|5/20/2026
|PENDING
|
|
|Katie Schieffer
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|Yiting Li (trainee);
Shashirekha Shetty (mentor)
|9/24/2025
|12/24/2025
|COMPLETE
|12/18/2025
|Katie Schieffer
|12/18/2025
|
|
|-
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|Disease
|Katherine Geiersbach
|8/11/2023
|11/11/2203
|COMPLETE
|1/8/2025
|Katherine Geiersbach
|1/8/2025
|
|
|
|
|
|-
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|Disease
|Disease
|
|
Line 422: Line 561:
|
|
|-
|-
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|3/1/2026
|6/30/2026
|COMPLETE
|3/3/2026
|Katie Schieffer
|3/4/2026
|
|-
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
|Disease
|Katie Schieffer
|4/21/2025
|10/1/2025
|COMPLETE
|9/18/2025
|Katie Schieffer
|9/18/2025
|
|-
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
|Disease
|Disease
|
|
Line 433: Line 595:
|
|
|-
|-
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
|Disease
|Disease
|
|
Line 444: Line 606:
|
|
|-
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
|Disease
|Disease
|
|
Line 455: Line 617:
|
|
|-
|-
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
|Disease
|Disease
|
|
Line 466: Line 628:
|
|
|-
|-
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
|Disease
|Disease
|
|
Line 477: Line 648:
|
|
|-
|-
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
|Disease
|Disease
|
|
Line 488: Line 659:
|
|
|-
|-
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|Disease
|Disease
|Shashi Shetty and Reba Daniel (resident)
|Katie Schieffer
|2/21/2024
|9/21/2025
|
|12/21/2025
|PENDING
|COMPLETE
|
|12/8/2025
|Katherine Geiersbach
|Katie Schieffer
|
|12/8/2025
|Template added 2/21/2024
|No genetic association
|-
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/10/2025
|Katie Schieffer
|11/10/2025
|No genetic association
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|-
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|Disease
|Disease
|
|
Line 510: Line 714:
|
|
|-
|-
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|Disease
|Disease
|
|
Line 521: Line 736:
|
|
|-
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|Disease
|Disease
|
|
Line 532: Line 747:
|
|
|-
|-
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|Disease
|Disease
|
|
Line 543: Line 767:
|
|
|-
|-
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|Disease
|Disease
|Katie Schieffer
|4/21/2025
|
|
|PENDING
|
|
|
|
|
|
|
Line 554: Line 778:
|
|
|-
|-
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|Minimal genetic content added
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|Minimal genetic content added
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|Disease
|Disease
|
|
Line 565: Line 811:
|
|
|-
|-
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|Disease
|Disease
|
|
Line 576: Line 822:
|
|
|-
|-
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|Disease
|Disease
|
|
Line 587: Line 833:
|
|
|-
|-
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|Disease
|Disease
|
|
Line 598: Line 844:
|
|
|-
|-
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|Disease
|Disease
|
|
Line 609: Line 855:
|
|
|-
|-
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
|[[STBT5:Glomus_tumour|Glomus tumour]]
|Disease
|Disease
|
|
Line 620: Line 866:
|
|
|-
|-
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|Disease
|Disease
|
|
Line 631: Line 886:
|
|
|-
|-
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|Disease
|Disease
|
|
Line 642: Line 897:
|
|
|-
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|[[STBT5:Leiomyoma|Leiomyoma]]
|Disease
|Disease
|
|
Line 653: Line 908:
|
|
|-
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|Disease
|Disease
|
|
Line 664: Line 930:
|
|
|-
|-
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|Disease
|Disease
|
|
Line 675: Line 941:
|
|
|-
|-
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|Disease
|Disease
|
|
Line 686: Line 952:
|
|
|-
|-
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 697: Line 963:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 708: Line 974:
|
|
|-
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 719: Line 985:
|
|
|-
|-
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 730: Line 1,005:
|
|
|-
|-
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|Disease
|Disease
|
|
Line 741: Line 1,016:
|
|
|-
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|Disease
|Disease
|Shanmugapriya Veeralakumar (trainee); Katie as mentor
|2/23/2026
|
|
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|Disease
|Disease
|
|
Line 763: Line 1,038:
|
|
|-
|-
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|Disease
|Disease
|
|
Line 774: Line 1,049:
|
|
|-
|-
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|[[STBT5:Schwannoma|Schwannoma]]
|Disease
|Disease
|
|
Line 785: Line 1,060:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|[[STBT5:Neurofibroma|Neurofibroma]]
|Disease
|Disease
|
|
Line 796: Line 1,071:
|
|
|-
|-
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|[[STBT5:Perineurioma|Perineurioma]]
|Disease
|Disease
|
|
Line 807: Line 1,082:
|
|
|-
|-
|[[STBT5:Glomus_tumour|Glomus tumour]]
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|Disease
|Disease
|
|
Line 818: Line 1,093:
|
|
|-
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|No genetic association
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|No genetic association
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|Disease
|Disease
|
|
Line 829: Line 1,135:
|
|
|-
|-
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|Disease
|Disease
|
|
Line 840: Line 1,146:
|
|
|-
|-
|[[STBT5:Leiomyoma|Leiomyoma]]
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|Disease
|Disease
|
|
Line 851: Line 1,157:
|
|
|-
|-
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|Disease
|
|
Line 862: Line 1,168:
|
|
|-
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|Disease
|
|
Line 873: Line 1,179:
|
|
|-
|-
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|Disease
|Disease
|
|
Line 884: Line 1,190:
|
|
|-
|-
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|Disease
|Disease
|
|
Line 895: Line 1,212:
|
|
|-
|-
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|Disease
|Disease
|
|
Line 906: Line 1,223:
|
|
|-
|-
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|Disease
|Disease
|
|
Line 917: Line 1,243:
|
|
|-
|-
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|Disease
|Disease
|
|
Line 928: Line 1,254:
|
|
|-
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|Disease
|Disease
|
|
Line 939: Line 1,265:
|
|
|-
|-
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|Disease
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|9/11/2025
|12/11/2025
|COMPLETE
|12/29/2026
|Katie Schieffer
|1/7/2026
|
|
|
|-
|
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|3/1/2026
|6/30/2026
|PENDING
|
|
|
|
Line 950: Line 1,289:
|
|
|-
|-
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|Disease
|Disease
|
|
Line 961: Line 1,300:
|
|
|-
|-
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|Disease
|James Solomon, MD, PhD
|2/20/2022
|12/9/2025
|COMPLETE
|2/26/2026
|Katie Schieffer
|2/26/2026
|
|-
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
|Disease
|Disease
|
|
Line 972: Line 1,322:
|
|
|-
|-
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|Disease
|Disease
|
|
Line 983: Line 1,333:
|
|
|-
|-
|[[STBT5:Schwannoma|Schwannoma]]
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|Disease
|Maxine Sutcliffe, PhD
|10/13/2025
|12/31/2025
|COMPLETE
|12/24/2025
|Katie Schieffer
|12/24/2025
|
|-
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|Disease
|Disease
|
|
Line 994: Line 1,355:
|
|
|-
|-
|[[STBT5:Neurofibroma|Neurofibroma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,005: Line 1,375:
|
|
|-
|-
|[[STBT5:Perineurioma|Perineurioma]]
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|Disease
|Disease
|
|Maxine Sutcliffe, PhD
|
|1/12/2026
|
|4/12/2026
|
|PENDING
|
|
|
|
Line 1,016: Line 1,386:
|
|
|-
|-
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|Disease
|Disease
|
|
Line 1,027: Line 1,397:
|
|
|-
|-
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|[[STBT5:PEComa|PEComa]]
|Disease
|Disease
|
|
Line 1,038: Line 1,408:
|
|
|-
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|Disease
|Disease
|
|
Line 1,049: Line 1,419:
|
|
|-
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|Disease
|Disease
|
|
Line 1,060: Line 1,430:
|
|
|-
|-
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|Disease
|
|
====CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
|
----
|
----
|-
|-
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|Disease
|Sadeem Qdaisat (trainee); Eric McGinnis (mentor)
|10/1/2023
|12/9/2025
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|Disease
|Disease
|
|
Line 1,093: Line 1,473:
|
|
|-
|-
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|Disease
|
|
Line 1,104: Line 1,484:
|
|
|-
|-
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|Disease
|Disease
|He Fang
|2/19/2026
|8/20/2026
|PENDING
|
|
|Katie Schieffer
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
|
====CHAPTER 4 (BONE TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|Disease
|
|
|
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|12/12/2025
|
|Katie Schieffer
|
|12/12/2025
|No genetic association
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|
|
|-
|-
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|Disease
|Disease
|
|
Line 1,148: Line 1,558:
|
|
|-
|-
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|[[STBT5:Enchondroma|Enchondroma]]
|Disease
|Disease
|
|
Line 1,159: Line 1,569:
|
|
|-
|-
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|[[STBT5:Osteochondroma|Osteochondroma]]
|Disease
|Disease
|
|
Line 1,170: Line 1,580:
|
|
|-
|-
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|
|-
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|Disease
|Disease
|
|
Line 1,181: Line 1,602:
|
|
|-
|-
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|Disease
|Disease
|
|
Line 1,192: Line 1,613:
|
|
|-
|-
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|Disease
|Disease
|
|
Line 1,203: Line 1,624:
|
|
|-
|-
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|Katie Schieffer
|9/21/2025
|12/31/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|Disease
|
|
Line 1,214: Line 1,646:
|
|
|-
|-
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|Disease
|James Solomon, MD, PhD
|2/20/2022
|
|PENDING
|
|Alanna Church
|
|
|-
|-
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,236: Line 1,666:
|
|
|-
|-
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,247: Line 1,677:
|
|
|-
|-
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,258: Line 1,688:
|
|
|-
|-
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,269: Line 1,699:
|
|
|-
|-
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,280: Line 1,710:
|
|
|-
|-
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,291: Line 1,721:
|
|
|-
|-
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|[[STBT5:Osteoma|Osteoma]]
|Disease
|Disease
|
|
Line 1,302: Line 1,732:
|
|
|-
|-
|[[STBT5:PEComa|PEComa]]
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|Disease
|Disease
|
|
Line 1,313: Line 1,743:
|
|
|-
|-
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|Disease
|Disease
|
|
Line 1,324: Line 1,754:
|
|
|-
|-
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|Disease
|Disease
|
|
Line 1,335: Line 1,765:
|
|
|-
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|Fang Fang (trainee); Katie Schieffer (mentor)
|11/19/2025
|4/15/2026
|PENDING
|
|Katie Schieffer
|
|
====CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)====
|
|
----
|-
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|Disease
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|Disease
|Disease
|Sadeem Qdaisat
|10/1/23
|
|
|PENDING
|
|
|Working with Eric McGinnis
|
|
|2021 template added
|
|
|
|
|
|-
|-
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|Disease
|Disease
|
|
Line 1,378: Line 1,818:
|
|
|-
|-
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|Disease
|Disease
|Ganesh Pandurang, MD
|2/28/24
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|Disease
|Disease
|
|
Line 1,400: Line 1,840:
|
|
|-
|-
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|
|
====CHAPTER 4 (BONE TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|-
|-
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|Disease
|
|[[STBT5:Epithelioid haemangioma|See STBT5: Epithelioid haemangioma page]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|Disease
|[[STBT5:Epithelioid haemangioendothelioma|See STBT5: Epithelioid haemangioendothelioma page]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|-
|
|-
|
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|[[STBT5:Angiosarcoma|See STBT5: Angiosarcoma page]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|Disease
|
|
Line 1,454: Line 1,915:
|
|
|-
|-
|[[STBT5:Enchondroma|Enchondroma]]
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|Disease
|
|
Line 1,465: Line 1,926:
|
|
|-
|-
|[[STBT5:Osteochondroma|Osteochondroma]]
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|Disease
|
|
Line 1,476: Line 1,937:
|
|
|-
|-
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|Disease
|
|
Line 1,487: Line 1,948:
|
|
|-
|-
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|Disease
|
|
Line 1,498: Line 1,959:
|
|
|-
|-
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association, early genetic studies referenced
|-
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|Disease
|
|
Line 1,509: Line 1,981:
|
|
|-
|-
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/22/2025
|Katie Schieffer
|10/22/2025
|
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|Disease
|
|
Line 1,531: Line 2,023:
|
|
|-
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|10/21/2025
|
|Katie Schieffer
|
|10/21/2025
|
|
|-
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|10/21/2025
|
|Katie Schieffer
|
|10/21/2025
|
|
|-
|-
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|Disease
|
|
Line 1,564: Line 2,056:
|
|
|-
|-
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|Disease
|
|
Line 1,575: Line 2,067:
|
|
|-
|-
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|Disease
|[[STBT5:Leiomyosarcoma|See STBT5: Leiomyosarcoma page]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|-
|
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|
|Disease
|
|Maxine Sutcliffe
|
|2/23/2026
|
|4/12/2026
|COMPLETE
|4/27/2026
|Katie Schieffer
|4/28/2026
|
|
|-
|-
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|10/21/2025
|
|Katie Schieffer
|
|10/21/2025
|
|
|-
|-
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|Disease
|
|
Line 1,608: Line 2,111:
|
|
|-
|-
|[[STBT5:Osteoma|Osteoma]]
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
|Disease
|Disease
|
|
Line 1,619: Line 2,122:
|
|
|-
|-
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
|Disease
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|
|
====CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)====
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|Disease
|
|
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|[[STBT5:Enchondromatosis|Enchondromatosis]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|
====CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[STBT5:Enchondromatosis|Enchondromatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
Line 2,056: Line 2,249:
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
|Disease
|
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
|[[STBT5:Werner_syndrome|Werner syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
Line 2,089: Line 2,260:
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Werner_syndrome|Werner syndrome]]
|Disease
|
|
|
|
|
|
|
|
|
|-
|-
|}<br />
|}<br />

Latest revision as of 04:20, 28 April 2026

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (SOFT TISSUE TUMOURS)
Lipoma Disease
Lipomatosis Disease
Lipomatosis of nerve Disease
Lipoblastoma and lipoblastomatosis Disease
Angiolipoma Disease
Myolipoma of soft tissue Disease
Chondroid lipoma Disease
Spindle cell lipoma and pleomorphic lipoma Disease
Hibernoma Disease
Atypical spindle cell / pleomorphic lipomatous tumour Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Atypical lipomatous tumour / well-differentiated liposarcoma Disease Kauser Begum Ravishankar (trainee), with Katie 2/25/2026 5/25/2026 PENDING Katie Schieffer
Dedifferentiated liposarcoma Disease
Myxoid liposarcoma Disease Karla Sofía Peláez Valdés (trainee);

Katie Schieffer (mentor)

3/1/2026 PENDING Katie Schieffer
Pleomorphic liposarcoma Disease
Myxoid pleomorphic liposarcoma Disease
Nodular fasciitis Disease
Proliferative fasciitis and proliferative myositis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025 Minimal genetic content added
Myositis ossificans and fibro-osseous pseudotumour of digits Disease
Ischaemic fasciitis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/16/2025 Katie Schieffer 10/16/2025 No genetic association
Elastofibroma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Fibrous hamartoma of infancy Disease
Fibromatosis colli Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 9/22/2025 Katie Schieffer 9/22/2025 No genetic association
Juvenile hyaline fibromatosis Disease
Inclusion body fibromatosis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/16/2025 Katie Schieffer 10/16/2025 No genetic association
Fibroma of tendon sheath Disease
Desmoplastic fibroblastoma Disease
Myofibroblastoma Disease
Calcifying aponeurotic fibroma Disease
EWSR1-SMAD3-positive fibroblastic tumour (emerging) Disease
Angiomyofibroblastoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Cellular angiofibroma Disease
Angiofibroma of soft tissue Disease
Nuchal-type fibroma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025 No genetic association
Acral fibromyxoma Disease
Gardner fibroma Disease
Palmar fibromatosis and plantar fibromatosis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 Minimal genetic content added
Desmoid fibromatosis Disease
Lipofibromatosis Disease
Giant cell fibroblastoma Disease
Dermatofibrosarcoma protuberans Disease He Fang 2/19/2026 5/20/2026 PENDING Katie Schieffer
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Solitary fibrous tumour Disease Yiting Li (trainee);

Shashirekha Shetty (mentor)

9/24/2025 12/24/2025 COMPLETE 12/18/2025 Katie Schieffer 12/18/2025
Inflammatory myofibroblastic tumour Disease Katherine Geiersbach 8/11/2023 11/11/2203 COMPLETE 1/8/2025 Katherine Geiersbach 1/8/2025
Low-grade myofibroblastic sarcoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Superficial CD34-positive fibroblastic tumour Disease
Myxoinflammatory fibroblastic sarcoma Disease Mokhtar Abdelhammed, MD (trainee);

Katie Schieffer (mentor)

3/1/2026 6/30/2026 COMPLETE 3/3/2026 Katie Schieffer 3/4/2026
Infantile fibrosarcoma Disease Katie Schieffer 4/21/2025 10/1/2025 COMPLETE 9/18/2025 Katie Schieffer 9/18/2025
Adult fibrosarcoma Disease
Myxofibrosarcoma Disease
Low-grade fibromyxoid sarcoma Disease
Sclerosing epithelioid fibrosarcoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Tenosynovial giant cell tumour Disease
Deep fibrous histiocytoma Disease
Plexiform fibrohistiocytic tumour Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025 No genetic association
Giant cell tumour of soft tissue Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Synovial haemangioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/10/2025 Katie Schieffer 11/10/2025 No genetic association
Intramuscular angioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Arteriovenous malformation/haemangioma Disease
Venous haemangioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Anastomosing haemangioma Disease
Epithelioid haemangioma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Lymphangioma and lymphangiomatosis Disease
Tufted angioma and kaposiform haemangioendothelioma Disease
Retiform haemangioendothelioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 Minimal genetic content added
Papillary intralymphatic angioendothelioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 Minimal genetic content added
Composite haemangioendothelioma Disease
Kaposi sarcoma Disease
Pseudomyogenic haemangioendothelioma Disease
Epithelioid haemangioendothelioma Disease
Angiosarcoma Disease
Glomus tumour Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Myopericytoma, including myofibroma Disease
Angioleiomyoma Disease
Leiomyoma Disease
EBV-associated smooth muscle tumour Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 No genetic association
Inflammatory leiomyosarcoma Disease
Leiomyosarcoma Disease
Rhabdomyoma Disease
Embryonal rhabdomyosarcoma Disease
Alveolar rhabdomyosarcoma Disease
Pleomorphic rhabdomyosarcoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Spindle cell / sclerosing rhabdomyosarcoma Disease
Ectomesenchymoma Disease
Gastrointestinal stromal tumour Disease Shanmugapriya Veeralakumar (trainee); Katie as mentor 2/23/2026 PENDING Katie Schieffer
Soft tissue chondroma Disease
Extraskeletal osteosarcoma Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Granular cell tumour Disease
Dermal nerve sheath myxoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 No genetic association
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Solitary circumscribed neuroma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 No genetic association
Ectopic meningioma and meningothelial hamartoma Disease
Benign triton tumour / neuromuscular choristoma Disease
Hybrid nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Malignant melanotic nerve sheath tumour Disease
Intramuscular myxoma Disease
Juxta-articular myxoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 No genetic association
Deep (aggressive) angiomyxoma Disease
Atypical fibroxanthoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Angiomatoid fibrous histiocytoma Disease
Ossifying fibromyxoid tumour Disease
Myoepithelioma, myoepithelial carcinoma, and mixed tumour Disease
Pleomorphic hyalinizing angiectatic tumour of soft parts Disease Mokhtar Abdelhammed, MD (trainee);

Katie Schieffer (mentor)

9/11/2025 12/11/2025 COMPLETE 12/29/2026 Katie Schieffer 1/7/2026
Haemosiderotic fibrolipomatous tumour Disease Mokhtar Abdelhammed, MD (trainee);

Katie Schieffer (mentor)

3/1/2026 6/30/2026 PENDING
Phosphaturic mesenchymal tumour Disease
NTRK-rearranged spindle cell neoplasm (emerging) Disease James Solomon, MD, PhD 2/20/2022 12/9/2025 COMPLETE 2/26/2026 Katie Schieffer 2/26/2026
Synovial sarcoma Disease
Epithelioid sarcoma Disease
Alveolar soft part sarcoma Disease Maxine Sutcliffe, PhD 10/13/2025 12/31/2025 COMPLETE 12/24/2025 Katie Schieffer 12/24/2025
Clear cell sarcoma of soft tissue Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Extraskeletal myxoid chondrosarcoma Disease
Desmoplastic small round cell tumour Disease Maxine Sutcliffe, PhD 1/12/2026 4/12/2026 PENDING
Extrarenal rhabdoid tumour Disease
PEComa Disease
Intimal sarcoma Disease
Undifferentiated sarcoma Disease

CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)
Ewing sarcoma Disease Sadeem Qdaisat (trainee); Eric McGinnis (mentor) 10/1/2023 12/9/2025 PENDING Katie Schieffer
Round cell sarcoma with EWSR1-non-ETS fusions Disease
CIC-rearranged sarcoma Disease
Sarcoma with BCOR genetic alterations Disease He Fang 2/19/2026 8/20/2026 PENDING Katie Schieffer
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 4 (BONE TUMOURS)
Subungual exostosis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 No genetic association
Bizarre parosteal osteochondromatous proliferation Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025
Periosteal chondroma Disease
Enchondroma Disease
Osteochondroma Disease
Chondroblastoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025
Chondromyxoid fibroma Disease
Osteochondromyxoma Disease
Synovial chondromatosis Disease
Central atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease Katie Schieffer 9/21/2025 12/31/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025
Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Central chondrosarcoma, grades 2 and 3 Disease
Secondary peripheral chondrosarcoma, grades 2 and 3 Disease
Periosteal chondrosarcoma Disease
Clear cell chondrosarcoma Disease
Mesenchymal chondrosarcoma Disease
Dedifferentiated chondrosarcoma Disease
Osteoma Disease
Osteoid osteoma Disease
Osteoblastoma Disease
Low-grade central osteosarcoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Osteosarcoma Disease Fang Fang (trainee); Katie Schieffer (mentor) 11/19/2025 4/15/2026 PENDING Katie Schieffer
Parosteal osteosarcoma Disease
Periosteal osteosarcoma Disease
High-grade surface osteosarcoma Disease
Secondary osteosarcoma Disease
Desmoplastic fibroma of bone Disease
Fibrosarcoma of bone Disease
Haemangioma of bone Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025 No genetic association
Epithelioid haemangioma of bone Disease See STBT5: Epithelioid haemangioma page N/A N/A N/A N/A N/A N/A
Epithelioid haemangioendothelioma of bone Disease See STBT5: Epithelioid haemangioendothelioma page N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Angiosarcoma of bone Disease See STBT5: Angiosarcoma page N/A N/A N/A N/A N/A N/A
Aneurysmal bone cyst Disease
Giant cell tumour of bone Disease
Non-ossifying fibroma Disease
Benign notochordal cell tumour Disease
Conventional chordoma Disease
Dedifferentiated chordoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025 No genetic association, early genetic studies referenced
Poorly differentiated chordoma Disease
Chondromesenchymal hamartoma of chest wall Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025 No genetic association
Osteofibrous dysplasia Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/22/2025 Katie Schieffer 10/22/2025
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Adamantinoma of long bones Disease
Simple bone cyst Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Fibrocartilaginous mesenchymoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Fibrous dysplasia Disease
Lipoma and hibernoma of bone Disease
Leiomyosarcoma of bone Disease See STBT5: Leiomyosarcoma page N/A N/A N/A N/A N/A N/A
Undifferentiated pleomorphic sarcoma Disease Maxine Sutcliffe 2/23/2026 4/12/2026 COMPLETE 4/27/2026 Katie Schieffer 4/28/2026
Bone metastases Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Solitary plasmacytoma of bone Disease
Primary non-Hodgkin lymphoma of bone Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Langerhans cell histiocytosis Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Erdheim-Chester disease Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Rosai-Dorfman disease Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A

CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)
Enchondromatosis Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
McCune-Albright syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Multiple osteochondromas Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Rothmund-Thomson syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Werner syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A


Retrieved from "https://content.ccga.io/index.php?title=STBT5:Volunteer_Assignments_and_Opportunities&oldid=21174"